Procter & Gamble Health logo

Procter & Gamble Health financials: balance sheet, profit and loss, cash flow

NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap

Procter & Gamble Health Limited · Formerly Merck · Face value ₹10 · Listed Jan 1982 on BSE, Apr 1996 on NSE
Last close ₹5,513.50up ₹114.50 (2.12%)BSE ₹5,510.60

Share price at the NSE close on 29 Oct 2026. Previous close ₹5,399.00.

29 Oct: open ₹5,399.00, high ₹5,540.00, low ₹5,380.50

52-week range of traded prices to 29 Oct 2026
₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026
Market cap
₹9,152 Cr585th largest listed
P/E
25.64
P/B
17.45
Dividend yield
3.72%
ROE
67.2%
ROCE
84.2%
Debt to equity
0.00
Volume, NSE
5,66357.6% delivered

Procter & Gamble Health's financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them. It had no borrowings at 31 Mar 2026.

10 years at a glance

₹ crore, years to December, then June, then March.Procter & Gamble Health annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
99676Dec 161,11994Dec 178498390Dec 18Jun 201,0091770Jun 211,1141930Jun 221,2302290Jun 231,1512010Jun 249342340Mar 251,4083270Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
34.1%7.6%17.4%24.4%24.1%26.3%26.6%34.1%32.4%7.6%8.4%17.5%17.3%18.7%17.5%25.1%23.2%Dec 16Dec 18Jun 21Jun 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 2.0% of operating profit in the first full year.

The company moved its year end from December to June: its last year to December on record ended in Dec 2018, its first year to June in Jun 2021. The company moved its year end from June to March: its last year to June on record ended in Jun 2024, its first year to March in Mar 2025.

The years either side of a change of basis do not compare. From the year to Dec 2018, the company's revenue for that year, ₹849 Cr, differs from its quarters added, ₹952 Cr; the company reports a discontinued business.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1,408
  2. Materials and goods−365
  3. Employee costs−223
  4. Other expenses−364
  5. Operating profit457
  6. Depreciation−24
  7. Other income+17
  8. One-off items0.0
  9. Finance costs−0.6
  10. Profit before tax450
  11. Tax−123
  12. Net profit327

What the company owns

  • Plant, investments and other assets₹355 Cr
  • Cash and bank₹185 Cr
  • Receivables₹164 Cr
  • Inventory₹137 Cr

What pays for it: net worth and liabilities

  • Net worth₹525 Cr
  • Owed to suppliers₹192 Cr
  • Other liabilities₹125 Cr

Profit and loss

Standalone, ₹ crore, years to December, then June, then March. No results on record for the year to Jun 2020. The last column is the twelve months to Jun 2026, the latest four quarters added.Procter & Gamble Health quarterly results

₹ croreDec 2016Dec 2017Dec 2018Filed 27 FebJun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026Jun 2026Twelve monthsFiled 6 Aug
Revenue from operations9961,119849–1,0091,1141,2301,1519341,4081,433
––702–763846906845616951967
Materials and goods bought413441269–315340362331263365367
Employee costs––131–150168206215142223227
Other expenses––301–297339338300211364373
Operating profit before depreciation––147–246268324306318457466
Operating margin––17.4%–24.4%24.1%26.3%26.6%34.1%32.4%32.5%
Materials, % of revenue––31.7%–31.2%30.5%29.4%28.7%28.1%25.9%25.6%
Employee costs, % of revenue––15.5%–14.9%15.0%16.8%18.7%15.2%15.8%15.8%
Other expenses, % of revenue––35.5%–29.5%30.4%27.5%26.0%22.6%25.8%26.0%
Depreciation and amortisation282620–30282727172424
Operating profit after depreciation––127–216241297279302433442
Other income242424–18131816101717
Finance costs––0–1011011
Profit before one-off items and tax110135151–233253314294312450458
One-off items–177–000−200032
Profit before tax110152158–233253314273312450490
345856–5661857277123133
Profit from discontinued businesses––737––––––––
Net profit7694839–177193229201234327357
Other comprehensive income––−2–01−21−301
Total comprehensive income––837–177193228202232327358
Net margin7.6%8.4%––17.5%17.3%18.7%17.5%25.1%23.2%24.9%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Dec 2016 and Dec 2017: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Net margin is left blank for the year to Dec 2018: the profit includes the result of a business the company has discontinued, which the revenue does not, so the two make no margin.
Earlier years, Dec 2007 to Dec 2015
₹ croreDec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015
Revenue from operations315390473512560687798867940
248340412435517––––
Materials and goods bought–5062208243299363400435
Employee costs–––6881––––
Other expenses–––159193––––
Operating profit before depreciation6750617743––––
Operating margin21.3%12.9%12.9%15.0%7.7%––––
Materials, % of revenue–––40.6%43.3%––––
Employee costs, % of revenue–––13.4%14.5%––––
Other expenses, % of revenue–––31.0%34.5%––––
Depreciation and amortisation768789101323
Operating profit after depreciation6044537035––––
Other income404743404620212023
Finance costs00000––––
Profit before one-off items and tax–929611081117886783
One-off items–––−1414––––
Profit before tax10092969696117886783
312931333238322330
Net profit696365636478564354
Net margin21.9%16.2%13.8%12.3%11.4%11.4%7.0%5.0%5.7%
Standalone, ₹ crore, years to December.

Balance sheet

Standalone, ₹ crore, at 31 December, then 30 June, then 31 March.

₹ croreDec 2018Filed 27 FebJun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
1,540–704616751538537525
Share capital17–171717171717
Reserves1,524–687600734522520508
Borrowings0–000000
196–239236304219215255
23–434146374262
1,759–9868941,101794794841
225–259196305270268285
1,534–727698796515526556
Net debt−1,243–−469−325−440−244−189−185
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Dec 2016 and Dec 2017, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to December, then June, then March.

₹ croreJun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
247170236228169338
315233326313250442
59−47−30−13−69−23
Receivables36−25−3329−60−15
Inventories16−2−32230−30
Payables2−764−72720
Other working capital6−14−296−162
Tax paid−68−64−90−85−81−104
Capital spending53384222016
Free cash flow195132194207169322
−32−26−22−7101
−387−289−98−418−235−344
Dividends paid38228494415232340
Shares bought back000000
Shares issued000000
Net change in cash−172−145116−197−56−5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Dec 2016, Dec 2017 and Dec 2018.

Per share

Standalone, ₹ per share, years to December, then June, then March.Procter & Gamble Health dividend history

₹ per shareDec 2016Dec 2017Dec 2018Filed 27 FebJun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Earnings per share–₹56.57₹505.27–₹106.50₹116.00₹138.23₹121.07₹141.22₹196.94
Diluted earnings per share–₹56.57₹505.27–₹106.50₹116.00₹138.23₹121.07₹141.22₹196.94
Dividend per share₹11.00₹15.00₹440.00–₹130.00₹52.50₹95.00₹260.00₹125.00₹205.00
Book value per share––₹927.83–₹423.92₹371.39₹452.34₹324.24₹323.47₹315.99
Dividend payout24.1%26.5%87.1%–122.1%45.3%68.7%214.7%88.5%104.1%
Shareholder yield––––4.1%4.1%1.1%5.0%2.7%4.3%
Market cap at the year end (₹ crore)1,6592,1415,110–9,2126,9578,7228,3838,5437,966

Ratios

Standalone, years to December, then June, then March.Procter & Gamble Health PE ratio and valuation

RatioDec 2016Dec 2017Dec 2018Filed 27 FebJun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Revenue growth6.0%12.4%–––10.5%10.3%−6.4%–50.7%
Operating profit growth–––––9.1%20.7%−5.5%–43.4%
Net profit growth41.7%23.7%–––8.9%19.2%−12.4%–39.5%
Earnings per share growth–––––8.9%19.2%−12.4%–39.5%
––54.5%–25.1%29.2%33.6%31.2%43.7%61.6%
–––––4.0 pts4.4 pts−2.4 pts–17.9 pts
From the net margin–––––−0.4 pts2.3 pts−2.2 pts–−3.3 pts
From asset turnover–––––3.9 pts1.3 pts−0.5 pts–18.7 pts
From borrowing–––––0.5 pts0.8 pts0.2 pts–2.5 pts
Return on capital employed––8.2%–30.7%39.0%39.5%51.8%56.2%82.6%
Cash conversion––––139.9%88.1%102.8%113.6%72.0%103.3%
Interest cover––––270.0572.9385.2386.9701.6787.4
Debt to equity––0.00–0.000.000.000.000.000.00
Receivable days––28–222734275743
Inventory days––154–137124136120152137
Payable days––124–149189239184239192
Cash conversion cycle, days––58–9−38−69−37−30−13
Working capital days––41–74515164830
Asset turnover––0.48–1.021.191.231.211.181.72
Assets per rupee of net worth––1.14–1.401.421.461.471.481.54
Sales per rupee of plant––8.55–10.0010.489.489.168.9314.19
Capital spending to depreciation––––1.751.361.550.790.000.66
Plant being built, % of plant in use––17.5%–38.8%38.2%25.1%4.7%10.5%13.7%
Revenue growth is left blank for the year to Dec 2018: between the two periods the company restated its earlier figures and the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. Net profit growth and earnings per share growth are left blank for the year to Dec 2018: between the two periods the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Dec 2016 and Dec 2017, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
40.0%
Cash from operations against operating profit
74.0%
Measure3 years
Return on equity, average52.6%
Return on capital employed, average69.4%
Operating margin, average33.3%
Net margin, average24.2%
Asset turnover, average1.45
Cash conversion cycle, days, average−21
Interest cover, average744.5
Debt to equity, average0.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations338
Cash from investing1
Cash from financing−344
Capital spending16
Dividends paid340
Shares bought back0
Shares issued for cash0
Borrowings raised0
Borrowings repaid0

Accounting checks

Standalone, years to December, then June, then March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckDec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Piotroski score, out of 9––––––75––
Altman Z-scorePublished threshold 1.81––16.88–22.9518.8018.4723.5923.7919.80
Beneish M-scorePublished threshold −1.78–––––−2.19−1.94−2.82–−2.39
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––––5.161.50−2.16–−1.48
Cash from operations to profit, 3 years––––––1.091.02––
Receivables growth less revenue growthOur threshold 0 percentage points–––––29.9228.34−19.88–−37.75
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––−10.6010.64−10.50–−14.14
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––8.41−5.62−2.52–−0.96
Assets under construction, years of additionsOur threshold 2 years of additions–––––1.220.640.25–0.75
Effective tax ratePublished threshold 17.16 per cent31.1538.3035.60–24.2124.0226.9726.4724.7827.33
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−1.19−1.57−4.70−1.324.25
A threshold marked as ours has no published figure; it is the line we read the check against.